Bayer CropScience Q2 Net Profit Climbs to Rs 1,662 Million

Revenue stood at Rs 12,507 million, while net profit grew to Rs 1,662 million compared to Rs 1,527 million in the year-ago period.

Reader Takeaway: Improved operational efficiency drove higher profits despite a seasonal revenue contraction in the Agri Care segment.

What just happened

Bayer CropScience Limited has reported its financial results for the quarter ended September 30, 2026. While the company saw a revenue decline to Rs 12,507 million from Rs 15,534 million in the same period last year, net profitability improved. The company also declared an interim dividend of Rs 90 per equity share for the financial year 2026-27.

Why this matters

The increase in net profit and EPS (Rs 36.98 vs Rs 33.98) indicates that the firm managed its costs effectively during a challenging top-line period. For retail investors, the substantial interim dividend of Rs 90 represents a significant capital return. The total payout for the company's 44,942,092 equity shares will amount to Rs 4,045 million.

The backstory

Bayer CropScience operates heavily in the Agri Care space, a sector notoriously subject to seasonal fluctuations. Management has previously highlighted that quarterly revenue volatility is often linked to the timing of monsoon cycles and crop seasons, which impacts sales volumes for their core crop protection products.

What changes now

Investors who wish to receive the declared dividend must ensure their names are in the Register of Members by the record date of Thursday, November 12, 2026. The actual payout is scheduled for Monday, November 30, 2026.

What to track next

Watch for upcoming revenue trends in the next two quarters to determine if the Q2 revenue dip is merely seasonal or a sign of softening demand in the wider Indian agrochemical market.